Therapeutic Area | MeSH |
---|---|
behavior and behavior mechanisms | D001520 |
mental disorders | D001523 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Narcolepsy | D009290 | EFO_0000614 | G47.4 | — | 1 | 2 | — | — | 3 |
Cataplexy | D002385 | — | — | — | 1 | 2 | — | — | 3 |
Sleepiness | D000077260 | — | R40.0 | — | 1 | 2 | — | — | 3 |
Disorders of excessive somnolence | D006970 | — | G47.1 | — | — | 2 | — | — | 2 |
Drug common name | Reboxetine |
INN | reboxetine |
Description | Reboxetine is an aromatic ether. |
Classification | Small molecule |
Drug class | antidepressants (fluoxetine type) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CCOc1ccccc1OC(c1ccccc1)C1CNCCO1 |
PDB | — |
CAS-ID | 105017-38-7 |
RxCUI | — |
ChEMBL ID | CHEMBL14370 |
ChEBI ID | — |
PubChem CID | 127151 |
DrugBank | DB00234 |
UNII ID | 947S0YZ36I (ChemIDplus, GSRS) |